BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 35990691)

  • 21. Hydroa vacciniforme-like lymphoproliferative disorder in Ecuadorian children: A case series.
    Garzón E; Dávila-Rodríguez JJ
    Indian J Dermatol Venereol Leprol; 2023; 89(3):403-407. PubMed ID: 33871198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epstein - Barr virus positive T and NK-cell lymphoproliferations: Morphological features and differential diagnosis.
    Montes-Mojarro IA; Kim WY; Fend F; Quintanilla-Martinez L
    Semin Diagn Pathol; 2020 Jan; 37(1):32-46. PubMed ID: 31889602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral manifestations of Hydroa vacciniforme-like lymphoproliferative disorder: a clinicopathological study of a Peruvian population.
    López de Cáceres CVB; Rodrigues-Fernandes CI; Rendón Henao J; Morais TML; Soares CD; de Almeida OP; Fonseca FP; Delgado-Azañero W
    J Oral Pathol Med; 2021 Jul; 50(6):530-539. PubMed ID: 34097774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydroa vacciniforme-like lymphoma with primarily periorbital swelling: 7 cases of an atypical clinical manifestation of this rare cutaneous T-cell lymphoma.
    Plaza JA; Sangueza M
    Am J Dermatopathol; 2015 Jan; 37(1):20-5. PubMed ID: 25162933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydroa vacciniforme-like lymphoproliferative disorder: Clinicopathologic study of 41 cases.
    Liu Y; Ma C; Wang G; Wang L
    J Am Acad Dermatol; 2019 Aug; 81(2):534-540. PubMed ID: 30654082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The understanding of Epstein-Barr virus associated lymphoproliferative disorder].
    Zhou XG; Zhang YL; Xie JL; Huang YH; Zheng YY; Li WS; Chen H; Liu F; Pan HX; Wei P; Wang Z; Hu YC; Yang KY; Xiao HL; Wu MJ; Yin WH; Mei KY; Chen G; Yan XC; Meng G; Xu G; Li J; Tian SF; Zhu J; Song YQ; Zhang WJ
    Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):817-821. PubMed ID: 28056294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicoprognostic Study of Hydroa Vacciniforme-like Lymphoproliferative Diseases: A Systematic Review.
    Kim YJ; Yang HJ; Won CH; Chang SE; Lee MW; Lee WJ
    Dermatology; 2023; 239(5):700-711. PubMed ID: 37231869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Common cytological and cytogenetic features of Epstein-Barr virus (EBV)-positive natural killer (NK) cells and cell lines derived from patients with nasal T/NK-cell lymphomas, chronic active EBV infection and hydroa vacciniforme-like eruptions.
    Zhang Y; Nagata H; Ikeuchi T; Mukai H; Oyoshi MK; Demachi A; Morio T; Wakiguchi H; Kimura N; Shimizu N; Yamamoto K
    Br J Haematol; 2003 Jun; 121(5):805-14. PubMed ID: 12780797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydroa vacciniforme-like lymphoproliferative disorder: A study of clinicopathology and whole-exome sequencing in Chinese patients.
    Xie Y; Wang T; Wang L
    J Dermatol Sci; 2020 Aug; 99(2):128-134. PubMed ID: 32682634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late-onset posttransplant Epstein-Barr virusrelated lymphoproliferative disease after cord blood transplantation for chronic active Epstein Barr virus infection: A case report.
    Yamamoto M; Shindo M; Funayama T; Sumi C; Saito T; Toki Y; Hatayama M; Imadome KI; Mizukami Y; Okumura T
    Medicine (Baltimore); 2022 Mar; 101(12):e29055. PubMed ID: 35357349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cutaneous EBV-related lymphoproliferative disorders.
    Gru AA; Jaffe ES
    Semin Diagn Pathol; 2017 Jan; 34(1):60-75. PubMed ID: 27988064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel, noninvasive diagnostic probe for hydroa vacciniforme and related disorders: detection of latency-associated Epstein-Barr virus transcripts in the crusts.
    Yamamoto T; Tsuji K; Suzuki D; Morizane S; Iwatsuki K
    J Microbiol Methods; 2007 Feb; 68(2):403-7. PubMed ID: 17141343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coexpression of natural killer cell antigens by T-cell large granular lymphocytes in hydroa vacciniforme lymphoproliferative disorder and the involvement of Vδ1 + epithelial-type γδT cells.
    Hirai Y; Iwatsuki K; Takahashi T; Miyake T; Nakagawa Y; Tanimoto S; Kawakami Y; Morizane S
    Int J Hematol; 2023 Jul; 118(1):54-64. PubMed ID: 37133637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydroa vacciniforme-like lymphoma: a chronic EBV+ lymphoproliferative disorder with risk to develop a systemic lymphoma.
    Quintanilla-Martinez L; Ridaura C; Nagl F; Sáez-de-Ocariz M; Durán-McKinster C; Ruiz-Maldonado R; Alderete G; Grube P; Lome-Maldonado C; Bonzheim I; Fend F
    Blood; 2013 Oct; 122(18):3101-10. PubMed ID: 23982171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association of latent Epstein-Barr virus infection with hydroa vacciniforme.
    Iwatsuki K; Xu Z; Takata M; Iguchi M; Ohtsuka M; Akiba H; Mitsuhashi Y; Takenoshita H; Sugiuchi R; Tagami H; Kaneko F
    Br J Dermatol; 1999 Apr; 140(4):715-21. PubMed ID: 10233328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NK-cell post-transplant lymphoproliferative disease successfully treated by second allogenic hematopoietic stem cell transplantation in chronic active Epstein-Barr virus infection.
    Shibata S; Takiuchi Y; Kawasaki N; Okamoto Y; Inano S; Fukunaga A; Tabata S; Arai A; Imadome KI; Kitano T
    Int J Hematol; 2022 Apr; 115(4):595-599. PubMed ID: 35001347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hydroa vacciniforme is associated with increased numbers of Epstein-Barr virus-infected γδT cells.
    Hirai Y; Yamamoto T; Kimura H; Ito Y; Tsuji K; Miyake T; Morizane S; Suzuki D; Fujii K; Iwatsuki K
    J Invest Dermatol; 2012 May; 132(5):1401-8. PubMed ID: 22297643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Central nervous system vasculitis from Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disorder in children: A case report.
    Lee MS; Hwang SK; Kim YE; Suh JK; Kim H; Lee SM; Jeong JY; Kwon S; Lee YJ
    Brain Dev; 2019 Oct; 41(9):820-825. PubMed ID: 31208818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008.
    Cohen JI; Kimura H; Nakamura S; Ko YH; Jaffe ES
    Ann Oncol; 2009 Sep; 20(9):1472-1482. PubMed ID: 19515747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A distinct subtype of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorder: adult patients with chronic active Epstein-Barr virus infection-like features.
    Kawamoto K; Miyoshi H; Suzuki T; Kozai Y; Kato K; Miyahara M; Yujiri T; Choi I; Fujimaki K; Muta T; Kume M; Moriguchi S; Tamura S; Kato T; Tagawa H; Makiyama J; Kanisawa Y; Sasaki Y; Kurita D; Yamada K; Shimono J; Sone H; Takizawa J; Seto M; Kimura H; Ohshima K
    Haematologica; 2018 Jun; 103(6):1018-1028. PubMed ID: 29242302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.